Pēd. atjaunots: 04.07.2024 14:06 (GMT+3)

Tallinna Farmaatsiatehas: Consolidated income statement 01.01-31.12.99

31.01.2000, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
INCOME STATEMENT

CONSOLIDATED INCOME STATEMENT 01.01-31.12.99

Consolidated, unaudited, in thousand EEK

Consolidated Parent
31.12.1999 31.12.1998 31.12.1999 31.12.1998
REVENUE
NET SALES 74811 83613 74811 83588

CHANGE IN INVENTORIES -2385 -4164 -2385 -4158
OTHER REVENUE 6365 234 6365 226
TOTAL REVENUE 78791 79683 78791 79657

EXPENSES
MATERIALS, CONSUMABLES AND SUPPLIES -31103 -42790 -31103 -42737
OTHER OPERATING EXPENSES -11752 -58509 -11752 -58276
PERSONNEL EXPENSES -16320 -22573 -16320 -21865
DEPRECIATION -5885 -9384 -5885 -9215
OTHER EXPENSES -4802 -27078 -4802 -27077
TOTAL EXPENSES -70053 -160334 -70053 -159170

OPERATING PROFIT (-LOSS) 8927 -80651 8927 -79513

INCOME/COST OF EQUITY HOLDING 3561 339 3561 339
OTHER FINANCIAL INCOME 190 816 190 575
AMORTIZATION OF GOODWILL -1513 -6136 -1513 -6136
OTHER FINANCIAL EXPENSES -5315 -10648 -5315 -11538
TOTAL -3077 -15629 -3077 -16760

PROFIT (-LOSS) BEFORE
INCOME TAX 5850 -96280 5850 -96273

INCOME TAX 3454 3454
Incl. DEFERRED INCOME TAX

PROFIT AFTER INCOME TAX -92826 -92819

NET PROFIT (-LOSS) FOR Q2

Earnings per share


Raivo Unt
Financial director
6120201

Vērtspapīri

Akcijas
Obligācijas
Ieguldījumu Fondi

Tirgus informācija

Statistika
Tirdzniecība
Indeksi
Izsoles

Noteikumi

Biržas noteikumi
Uzraudzība

Nāc uz Biržu

Uzņēmumiem
Investoriem
Biržas biedriem
First North konsultantiem

Aktualitātes

Nasdaq ziņas
Emitentu ziņas
Kalendārs

Par mums

Nasdaq Baltijas tirgus
Biroji